Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™
Approval issued by the Health Authority of Colombia INVIMA for Adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) Approval issued by the Health Authority of Colombia INVIMA for Adjuvant treatment for seizure…
TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and com…